Cargando…
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
The field of induced proximity therapeutics is in its ascendancy but is limited by a lack of scalable tools to systematically explore effector-target protein pairs in an unbiased manner. Here, we combined Scalable POoled Targeting with a LIgandable Tag at Endogenous Sites (SPOTLITES) for the high-th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543026/ https://www.ncbi.nlm.nih.gov/pubmed/37790450 http://dx.doi.org/10.21203/rs.3.rs-3161717/v1 |
_version_ | 1785114210659729408 |
---|---|
author | Serebrenik, Yevgeniy V. Mani, Deepak Maujean, Timothé Burslem, George M. Shalem, Ophir |
author_facet | Serebrenik, Yevgeniy V. Mani, Deepak Maujean, Timothé Burslem, George M. Shalem, Ophir |
author_sort | Serebrenik, Yevgeniy V. |
collection | PubMed |
description | The field of induced proximity therapeutics is in its ascendancy but is limited by a lack of scalable tools to systematically explore effector-target protein pairs in an unbiased manner. Here, we combined Scalable POoled Targeting with a LIgandable Tag at Endogenous Sites (SPOTLITES) for the high-throughput tagging of endogenous proteins, with generic small molecule-based protein recruitment to screen for novel proximity-based effectors. We apply this methodology in two orthogonal screens for targeted protein degradation: the first using fluorescence to monitor target protein levels directly, and the second using a cellular growth phenotype that depends on the degradation of an essential protein. Our screens revealed a multitude of potential new effector proteins for degradation and converged on members of the CTLH complex which we demonstrate potently induce degradation. Altogether, we introduce a platform for pooled induction of endogenous protein-protein interactions that can be used to expand our toolset of effector proteins for targeted protein degradation and other forms of induced proximity. |
format | Online Article Text |
id | pubmed-10543026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-105430262023-10-03 Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics Serebrenik, Yevgeniy V. Mani, Deepak Maujean, Timothé Burslem, George M. Shalem, Ophir Res Sq Article The field of induced proximity therapeutics is in its ascendancy but is limited by a lack of scalable tools to systematically explore effector-target protein pairs in an unbiased manner. Here, we combined Scalable POoled Targeting with a LIgandable Tag at Endogenous Sites (SPOTLITES) for the high-throughput tagging of endogenous proteins, with generic small molecule-based protein recruitment to screen for novel proximity-based effectors. We apply this methodology in two orthogonal screens for targeted protein degradation: the first using fluorescence to monitor target protein levels directly, and the second using a cellular growth phenotype that depends on the degradation of an essential protein. Our screens revealed a multitude of potential new effector proteins for degradation and converged on members of the CTLH complex which we demonstrate potently induce degradation. Altogether, we introduce a platform for pooled induction of endogenous protein-protein interactions that can be used to expand our toolset of effector proteins for targeted protein degradation and other forms of induced proximity. American Journal Experts 2023-09-13 /pmc/articles/PMC10543026/ /pubmed/37790450 http://dx.doi.org/10.21203/rs.3.rs-3161717/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Serebrenik, Yevgeniy V. Mani, Deepak Maujean, Timothé Burslem, George M. Shalem, Ophir Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
title | Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
title_full | Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
title_fullStr | Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
title_full_unstemmed | Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
title_short | Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
title_sort | pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543026/ https://www.ncbi.nlm.nih.gov/pubmed/37790450 http://dx.doi.org/10.21203/rs.3.rs-3161717/v1 |
work_keys_str_mv | AT serebrenikyevgeniyv pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics AT manideepak pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics AT maujeantimothe pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics AT burslemgeorgem pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics AT shalemophir pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics |